Susquehanna International Group
ORMP icon

Susquehanna International Group’s Oramed Pharmaceuticals ORMP Stock Holding History

Susquehanna International Group’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,000
Closed -$38.7K – 13191
2024
Q4 		$38.7K Buy
+16,000
New +$38K ﹤0.01% 11772
2023
Q1 		– Sell
-153,600
Closed -$1.85M – 13221
2022
Q4 		$1.85M Buy
153,600
+88,100
+135% +$685K ﹤0.01% 4858
2022
Q3 		$424K Buy
65,500
+36,100
+123% +$292K ﹤0.01% 8910
2022
Q2 		$135K Sell
29,400
-34,200
-54% -$183K ﹤0.01% 11158
2022
Q1 		$550K Sell
63,600
-34,100
-35% -$349K ﹤0.01% 8735
2021
Q4 		$1.4M Buy
97,700
+21,100
+28% +$441K ﹤0.01% 6398
2021
Q3 		$1.68M Buy
76,600
+59,000
+335% +$1M ﹤0.01% 6207
2021
Q2 		$235K Sell
17,600
-7,000
-28% -$80.1K ﹤0.01% 11256
2021
Q1 		$250K Buy
+24,600
New +$202K ﹤0.01% 10984
2020
Q1 		– Sell
-15,400
Closed -$79K – 10700
2019
Q4 		$79K Buy
+15,400
New +$57.7K ﹤0.01% 9221
2016
Q3 		– Sell
-11,700
Closed -$98K – 8855
2016
Q2 		$98K Sell
11,700
-8,600
-42% -$73.3K ﹤0.01% 8032
2016
Q1 		$135K Buy
20,300
+2,400
+13% +$16.1K ﹤0.01% 8278
2015
Q4 		$153K Buy
+17,900
New +$136K ﹤0.01% 8641
2015
Q3 		– Sell
-19,500
Closed -$111K – 10006
2015
Q2 		$111K Buy
19,500
+5,700
+41% +$39K ﹤0.01% 9634
2015
Q1 		$88K Sell
13,800
-1,600
-10% -$7.73K ﹤0.01% 9007
2014
Q4 		$70K Sell
15,400
-12,300
-44% -$80.9K ﹤0.01% 9293
2014
Q3 		$223K Sell
27,700
-24,800
-47% -$220K ﹤0.01% 8496
2014
Q2 		$505K Buy
+52,500
New +$536K ﹤0.01% 7459

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's ORMP Position: Q1 2026 in Review

Susquehanna International Group increased its Oramed Pharmaceuticals (ORMP) stake by 424% in Q1 2026, buying an estimated $374K and bringing the position to 136,218 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #9875.

Susquehanna International Group first reported a position in ORMP in Q1 2014 and has held it in 30 quarters since. The position peaked at $2.23M in Q4 2022. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Susquehanna International Group held 136,218 shares of Oramed Pharmaceuticals worth $463K as of Q1 2026.
  • Susquehanna International Group bought 110,234 Oramed Pharmaceuticals shares in Q1 2026, an estimated $374K.
  • Oramed Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9875 holding.
  • Susquehanna International Group first reported a position in Oramed Pharmaceuticals in Q1 2014 and has held it in 30 quarters since.
  • Susquehanna International Group's Oramed Pharmaceuticals position peaked at $2.23M in Q4 2022.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.